Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02642991 · ClinicalTrials.gov registry record · NA
Dispensing Study for a New Study Lens
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT02642991 is a NA study that has completed, run by CooperVision. The registered enrollment target is 44 participants.
The verdict
NCT02642991, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study investigated the performance criteria over one week of daily wear to determine if the comfilcon A asphere lens (test) performed equivalently to the comfilcon A sphere (control) in terms of measurement and subjective ratings of visual performance.
Interventions
- DEVICE comfilcon A
- DEVICE Phenacite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02642991
The ClinicalTrials.gov registry entry for NCT02642991 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which comfilcon A is the first listed.
NCT02642991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02642991 about?
NCT02642991 is a clinical study titled "Dispensing Study for a New Study Lens". This study investigated the performance criteria over one week of daily wear to determine if the comfilcon A asphere lens (test) performed equivalently to the comfilcon A sphere (control) in terms of measurement and subjective ratings of visual performance.
What is the current status of trial NCT02642991?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-11. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02642991?
The interventions under investigation include: comfilcon A (DEVICE), Phenacite (DEVICE).
Who is sponsoring clinical trial NCT02642991?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.